Experimental and clinical background
Validation in experimental studies
In vitro and in vivo experimental studies have shown a pathophysiological role of ApoJ-Glyc in ischemic disease.
Link to publication
01
Early decrease in ApoJ-Glyc circulating levels upon ischemia induction
02
Intracellular accumulation of ApoJ-Glyc upon ischemia induction
03
Progressive decrease of ApoJ-Glyc release with ischemia
Our studies have demonstrated for the first time the association between decreased ApoJ-Glyc levels and ischemia induced changes in cardiac cells
Let's get in touch
